Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study
Clinical trial NCT07589049 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07589049
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.